Navigation Links
Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
Date:4/2/2009

Microbia, Inc. (Microbia), an emerging leader in the production of sustainable, specialty ingredients and biomaterials from fermentation technology, has announced that Mike Doyle has joined the company as senior vice president and general manager of nutrition ingredients. Mike is the former director of nutrition health business for BASF and will lead Microbia's food ingredients business initiatives. For more information about Microbia, please go to http://www.microbia-pe.com/.

Lexington, Mass., April 2, 2009-- Microbia, Inc. (Microbia), an emerging leader in the production of sustainable, specialty ingredients and biomaterials from fermentation technology, has appointed Mike Doyle to the newly created position of senior vice president and general manager of nutrition ingredients. Mr. Doyle will have broad responsibility for all aspects of Microbia's nutrition ingredients business, including strategic planning, marketing, sales, operations, supply chain management and strategic partnerships in preparation for the launch of Microbia's line of naturally derived carotenoids for the food ingredient and nutritional supplement markets.

"Microbia's goal is to utilize our proprietary, bio-based technology platform to produce nutritional ingredients that will help the food and feed industries make products more innovative, cost-effective and environmentally sustainable," said Richard Bailey, Ph.D., CEO of Microbia. "Mike Doyle has the experience, energy and skills required to lead this effort, and holds a track record of success managing relevant nutrition businesses. We look forward to drawing on his substantial expertise to establish a strong position in the nutrition ingredients marketplace."

"I am eager to help Microbia bring the vast promise of its exciting technology to market," said Mr. Doyle. "Microbia has a significant competitive position based on its advanced metabolic engineering innovations. Our goal is to become a leading global supplier of nutrition ingredients that deliver significant added value to our customers in the feed, food, beverage, and dietary supplement industries."

Mike Doyle brings more than 12 years of executive management experience to Microbia, including as director, human nutrition for BASF's North American business, and most recently, as president of LycoRed, Corp. in North America. While at BASF, Mr. Doyle oversaw development and marketing of vitamins, carotenoids, food and beverage polymers, and other food ingredients. At LycoRed Corp., Mr. Doyle was responsible for all operations in the North American marketplace. Mr. Doyle is also a former board member and Treasurer of the Council for Responsible Nutrition. He received a B.S. degree in marketing and industrial management from New York University, and an M.B.A. from Michigan State University.

ABOUT MICROBIA (WWW.MICROBIA-PE.COM)
Microbia is an industrial biotechnology company applying proprietary metabolic engineering to create cost-effective, renewable specialty ingredients and biomaterials. Microbia will develop and commercialize its products through direct sales and strategic alliances, including an ongoing multi-product joint development and commercialization agreement with Tate & Lyle Investments, Ltd. Microbia's carotenoids will be the first products launched from a diverse pipeline of specialty ingredients, biopolymers and other biomaterials. Microbia was established in 2006 as a majority-owned subsidiary of Ironwood Pharmaceuticals, Inc. and is based in Lexington, Massachusetts.

###

Read the full story at http://www.prweb.com/releases/Microbia/Doyle/prweb2294664.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. KGI Names Kerry Howell Vice President for Advancement
2. Vical Names Andrew de Guttadauro Vice President, Corporate Development
3. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
4. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
5. CryoLife Names Philip Theodore as Vice President, General Counsel
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. PPD Names Daniel Darazsdi as Chief Financial Officer
8. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
9. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
10. Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
11. Osprey Pharmaceuticals Names Jack M. Anthony as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today provided ... Uniden in the Northern District of Texas ... forward.  Inter Partes Re-examination ("IPR") ... Patent Office.  The IPR was initiated on only certain ...
(Date:2/4/2016)... ... ... Many of the engineers at FireflySci, Inc. have been manufacturing quartz and ... cuvette manufacturers is their supercharged customer service and their extensive database of glass cuvette ... of inside information, they have recently revamped their manufacturing techniques to reduce lead times ...
(Date:2/3/2016)... Denmark , Feb. 3, 2016 Ascendis ... biotechnology company that applies its innovative TransCon technology to ... present at an upcoming investor conference.Event:2016 Leerink Partners Global ... NY Date:  , Wednesday, February 10, 2016 Time:  ... www.ascendispharma.com . --> An audio webcast ...
(Date:2/3/2016)... ON (PRWEB) , ... February 03, 2016 , ... ... and validating a series of potential targets (epitopes) specific to misfolded, propagating strains ... targets to create specific monoclonal antibody therapeutics for Alzheimer’s. , Following on from ...
Breaking Biology Technology:
(Date:2/3/2016)... Sweden , February 4, 2016 --> ... amounted to SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter ... profit amounted to SEK 517.6 M (loss: 30.0). Earnings per ... operating activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared ...
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
Breaking Biology News(10 mins):